CSPC Innovation Pharmaceutical Co., Ltd. (300765.SZ)
CNY 43.93
(-1.83%)
CNY 43.93
(-1.83%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 841.21 Thousand CNY | -95.75% |
| 2022 | 19.8 Million CNY | 0.0% |
| 2021 | - CNY | -100.0% |
| 2020 | 840.95 Thousand CNY | 84095600.63% |
| 2019 | 1.00 CNY | 0.0% |
| 2018 | - CNY | -100.0% |
| 2017 | 50 Million CNY | 0.0% |
| 2016 | - CNY | -100.0% |
| 2015 | 120 Million CNY | 0.0% |
| 2014 | - CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q3 | 213.69 Thousand CNY | 0.0% |
| 2024 Q1 | 634.27 Thousand CNY | 0.0% |
| 2024 Q2 | 425.1 Thousand CNY | 0.0% |
| 2023 Q1 | 19.7 Million CNY | -0.51% |
| 2023 FY | 841.21 Thousand CNY | -95.75% |
| 2023 Q4 | 841.21 Thousand CNY | -19.54% |
| 2023 Q3 | 1.04 Million CNY | -95.01% |
| 2023 Q2 | 20.94 Million CNY | 6.33% |
| 2022 Q3 | - CNY | 100.0% |
| 2022 FY | 19.8 Million CNY | 0.0% |
| 2022 Q4 | 19.8 Million CNY | 0.0% |
| 2022 Q1 | - CNY | 0.0% |
| 2022 Q2 | - CNY | 0.0% |
| 2021 Q1 | 1.44 Million CNY | 0.0% |
| 2021 Q4 | - CNY | -100.0% |
| 2021 FY | - CNY | -100.0% |
| 2021 Q2 | 425.02 Thousand CNY | -70.65% |
| 2021 Q3 | 231.46 Thousand CNY | -45.54% |
| 2020 FY | 840.95 Thousand CNY | 84095600.63% |
| 2020 Q1 | - CNY | -100.0% |
| 2020 Q2 | - CNY | 0.0% |
| 2020 Q3 | - CNY | 0.0% |
| 2020 Q4 | - CNY | 100.0% |
| 2019 Q4 | 1.00 CNY | 0.0% |
| 2019 FY | 1.00 CNY | 0.0% |
| 2019 Q2 | - CNY | 0.0% |
| 2019 Q1 | - CNY | 0.0% |
| 2019 Q3 | - CNY | 0.0% |
| 2018 Q1 | - CNY | -100.0% |
| 2018 Q4 | - CNY | 0.0% |
| 2018 Q2 | 50 Million CNY | 0.0% |
| 2018 FY | - CNY | -100.0% |
| 2017 Q4 | 50 Million CNY | 0.0% |
| 2017 FY | 50 Million CNY | 0.0% |
| 2017 Q1 | - CNY | 0.0% |
| 2017 Q2 | - CNY | 0.0% |
| 2017 Q3 | 50 Million CNY | 0.0% |
| 2016 FY | - CNY | -100.0% |
| 2015 FY | 120 Million CNY | 0.0% |
| 2014 FY | - CNY | 0.0% |